Sinovac Biotech News

About 67% of Sinovac Biotech's investor base is looking to short. The analysis of overall sentiment of trading Sinovac Biotech stock suggests that many investors are alarmed at this time. Sinovac Biotech's investor sentiment overview provides quick insight into current market opportunities from investing in Sinovac Biotech. The current market sentiment, together with Sinovac Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use Sinovac Biotech stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Sinovac Biotech stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Sinovac daily returns and investor perception about the current price of Sinovac Biotech as well as its diversification or hedging effects on your existing portfolios.
  
over a month ago at investing.com         
Disposition of 9000 shares by Gillies Hunter of Aerovate Therapeutics at 29.5 subject to Rule 16b-3
Investing News at Macroaxis
over two weeks ago at news.google.com         
Disposition of 771 shares by George Eldridge of Aerovate Therapeutics at 27.5646 subject to Rule 16b...
Google News at Macroaxis
over two weeks ago at news.google.com         
Anebulo Pharmaceuticals Announces Pricing of Initial Public Offering - The Globe and Mail
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
Anebulo Pharmaceuticals, Inc. Short Interest Update
news
over a month ago at www.macroaxis.com         
Acquisition by Rodman David Malcom of 5017 shares of Mineralys Therapeutics at 0.54 subject to Rule ...
Macroaxis News
over a month ago at finance.yahoo.com         
Mineralys Therapeutics, Inc. Q4 2023 Earnings Call Transcript
Yahoo News
over two months ago at bizjournals.com         
Mineralys Therapeutics set to raise 120M from investors to develop treatment for high blood pressure
bizjournals News
3 days ago at investing.com         
Disposition of 3250 shares by Benjamin Hohl of Enliven Therapeutics at 16.9737 subject to Rule 16b-3
Investing News at Macroaxis
six days ago at www.macroaxis.com         
Disposition of 12000 shares by Kintz Samuel of Enliven Therapeutics at 16.8917 subject to Rule 16b-3
Macroaxis News
over two weeks ago at finance.yahoo.com         
Disposition of 48820 shares by Ballal Rahul D. of Enliven Therapeutics at 12.6 subject to Rule 16b-3
Yahoo News
over a month ago at news.google.com         
Disposition of 182 shares by Benjamin Hohl of Enliven Therapeutics at 18.7186 subject to Rule 16b-3
Google News at Macroaxis
over two weeks ago at news.google.com         
Adagene Inc. Short Interest Down 38.6 percent in March - MarketBeat
Google News at Macroaxis
over two months ago at finance.yahoo.com         
Adagene to Present at the Leerink Partners Global Biopharma Conference 2024
Yahoo News
over two months ago at thelincolnianonline.com         
Adagene Inc. Sees Significant Increase in Short Interest
news
over two weeks ago at investing.com         
Crinetics Pharmaceuticals executive sells shares worth over 639k
Investing News at Macroaxis
over a month ago at news.google.com         
Technical Analysis of Crinetics Pharmaceuticals TradingView News - TradingView
Google News at Macroaxis
over a month ago at finance.yahoo.com         
Crinetics Pharmaceuticals Announces March 2024 Inducement Grants UnderNasdaq Listing Rule 5635
Yahoo News
over a week ago at finance.yahoo.com         
Cytokinetics to Announce First Quarter Results on May 8, 2024
Yahoo News
over three weeks ago at gurufocus.com         
Disposition of 28605 shares by Fady Malik of Cytokinetics at 6.67 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over three weeks ago at benzinga.com         
100 Invested In Cytokinetics 5 Years Ago Would Be Worth This Much Today
benzinga news
over three weeks ago at finance.yahoo.com         
Got 3,000 2 Monster Growth Stocks to Buy Right Now Without Hesitation
Yahoo News
over a week ago at globenewswire.com         
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial fo...
Macroaxis News: globenewswire.com
over two weeks ago at news.google.com         
International Assets Investment Management LLC Acquires Shares of 55120 Cerevel Therapeutics Holding...
Google News at Macroaxis
over a week ago at news.google.com         
Discretionary transaction by Baker Bros. Advisors Lp of 4342429 shares of Bicycle Therapeutics subje...
Google News at Macroaxis
over three weeks ago at investing.com         
Bicycle therapeutics CSO sells shares worth over 18k
Investing News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 31000 shares by Hannay Michael Charles Ferguson of Bicycle Therapeutics at 18.08 subj...
Macroaxis News
over six months ago at news.google.com         
SG Americas Securities LLC Surprises the Market with Dramatic ... - Best Stocks
Google News at Macroaxis
over six months ago at accesswire.com         
INVESTIGATION ALERT The Schall Law Firm Announces it is Investigating Claims Against Chinook Therape...
news
over two weeks ago at finance.yahoo.com         
The past five years for Alector investors has not been profitable
Yahoo News
over a month ago at news.google.com         
Disposition of tradable shares by Desouza Errol B of Alector subject to Rule 16b-3
Google News at Macroaxis
over a month ago at www.macroaxis.com         
Disposition of 10169 shares by Kenkare-mitra Sara of Alector at 6.9217 subject to Rule 16b-3
Macroaxis News
over two months ago at thelincolnianonline.com         
Alector Earns Buy Rating from HC Wainwright
news
over two weeks ago at businesswire.com         
Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results
businesswire News
over three weeks ago at news.google.com         
HC Wainwright Reiterates Buy Rating for Legend Biotech - Defense World
Google News at Macroaxis
over a month ago at finance.yahoo.com         
Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance Report
Yahoo News
over a week ago at globenewswire.com         
United Kingdoms MHRA Approves YORVIPATH in Great Britain for the Treatment of Adults with Chronic Hy...
Macroaxis News: globenewswire.com
over two weeks ago at benzinga.com         
Ascendis Pharmas Options Frenzy What You Need to Know
benzinga news
over a month ago at news.google.com         
Ascendis Pharma and MoonLake Immunotherapeutics dropped from Wedbush list By Investing.com - Investi...
Google News at Macroaxis
over a week ago at businesswire.com         
Edgewise Receives European Medicines Agency Orphan Drug Designations for Sevasemten for the Treatmen...
businesswire News
over two weeks ago at finance.yahoo.com         
Edgewise Therapeutics Announces Positive Two-Year Topline Results from the ARCH Open Label Trial of ...
Yahoo News
over three weeks ago at www.macroaxis.com         
Disposition of 17993 shares by John Moore of Edgewise Therapeutics at 1.93 subject to Rule 16b-3
Macroaxis News
over a month ago at news.google.com         
Edgewise Therapeutics Shares Down 5.8 percent - MarketBeat
Google News at Macroaxis
a day ago at investing.com         
Assembly Biosciences executive sells over 15k in stock
Investing News at Macroaxis
3 days ago at newsweek.com         
Social Security benefits could be changed for thousands of children
news
six days ago at autoblog.com         
Way Day 2024 is here - find great deals on home, garden, patio, and garage essentials during the Way...
news
over a month ago at news.google.com         
Spero Therapeutics to Announce Quarterly Earnings on Wednesday - MarketBeat
Google News at Macroaxis
over a month ago at seekingalpha.com         
Spero Therapeutics files 300M mixed securities shelf
seekingalpha News
over three weeks ago at investing.com         
Piper Sandler violently slashes Achilles Therapeutics shares target, CHIRON data disappoints
Investing News at Macroaxis
over two months ago at news.google.com         
Achilles Therapeutics plc Short Interest Update - Defense World
Google News at Macroaxis
over a week ago at businesswire.com         
Obsidian Therapeutics to Present Clinical Data from OBX-115, its Engineered TIL Cell Therapy, for Pa...
businesswire News
over two weeks ago at seekingalpha.com         
Jefferies cuts Instill Bio to hold, cites drug discontinuation
seekingalpha News
over a month ago at news.google.com         
Down 59.5 percent in 4 Weeks, Heres Why You Should You Buy the Dip in Instil Bio, Inc. - Yahoo Movie...
Google News at Macroaxis
over two months ago at aol.com         
Cancer treatment FDA approves type of cell therapy for patients with late-stage melanoma
news
over three months ago at news.google.com         
Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split - GlobeNewswire
Google News at Macroaxis
over a week ago at accesswire.com         
Levi Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio Law...
news
over a month ago at news.google.com         
Exchange Traded Concepts LLC Has 229000 Stock Holdings in Mersana Therapeutics, Inc. - Defense World
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
Mersana Therapeutics - Investment Analysts Recent Ratings Changes
news
over two months ago at investing.com         
Earnings call Mersana Therapeutics reports on ADC development progress
Investing News at Macroaxis
over two months ago at seekingalpha.com         
Zentalis files automatic mixed securities shelf
seekingalpha News
over three weeks ago at benzinga.com         
Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib...
benzinga news
over two months ago at globenewswire.com         
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
Macroaxis News: globenewswire.com
six days ago at benzinga.com         
Y-mAbs to Present at 2024 ASCO Annual Meeting
benzinga news
over three weeks ago at simplywall.st         
Y-mAbs Therapeutics Insiders Who Sold Avert US91m Market Cap Dip
Simply Wall St News at Macroaxis
over a month ago at zacks.com         
Wall Street Analysts See a 31.41 percent Upside in Y-mAbs Therapeutics, Inc. Can the Stock Really Mo...
zacks News
over two weeks ago at investing.com         
Travere Therapeutics CFO sells shares to cover tax obligations
Investing News at Macroaxis
over a week ago at globenewswire.com         
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI for the treatment ...
Macroaxis News: globenewswire.com
over a month ago at news.google.com         
Where Will Travere Therapeutics Inc Stock Go Next After It Has Fallen 2.45 percent in a Week - Inves...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Sinovac Biotech that are available to investors today. That information is available publicly through Sinovac media outlets and privately through word of mouth or via Sinovac internal channels. However, regardless of the origin, that massive amount of Sinovac data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sinovac Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sinovac Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sinovac Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sinovac Biotech alpha.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Consideration for investing in Sinovac Stock

If you are still planning to invest in Sinovac Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sinovac Biotech's history and understand the potential risks before investing.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Transaction History
View history of all your transactions and understand their impact on performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation